Content reviewed by clinical research staff

Last reviewed: March 2026Sources: PubMed, FDA, WADA Prohibited List

Evidence graded using the PeptideScholar A-D system.

Kisspeptin-10

KISS1R agonist peptide (metastin fragment)10 amino acids

BHuman Studies
85
Excellent Credibility
4 cited studies | Evidence level B

Kisspeptin-10 is the minimal active fragment of kisspeptin (metastin), the endogenous ligand for the KISS1 receptor (GPR54). It is a potent stimulator of the hypothalamic-pituitary-gonadal (HPG) axis, triggering GnRH release and downstream LH/FSH secretion. First identified for its anti-metastatic properties in melanoma, it is now primarily studied for reproductive medicine applications including fertility treatment and hypothalamic amenorrhea.

Mechanism of Action

Binds to and activates the KISS1 receptor (GPR54/KISS1R) on hypothalamic GnRH neurons. This stimulates pulsatile GnRH release into the hypophyseal portal system, which in turn triggers the anterior pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Unlike exogenous gonadotropins, kisspeptin preserves physiological pulsatile hormone secretion patterns. Also modulates oxytocin release in a sex-dependent manner.

Benefits

  • Triggers egg maturation in women undergoing IVF — demonstrated in clinical studies[3]
  • Stimulates gonadotropin secretion without causing the hormonal surge crash seen with GnRH agonists[1]
  • Modulates reproductive hormones in PCOS patients without hyperstimulation[4]
  • May have therapeutic potential for hypothalamic amenorrhea and delayed puberty[1]
Not medical advice - research-reported information only

This content is for informational purposes only and does not constitute medical advice.

Kisspeptin-10 - Dosing in Published Research

Reported routes: Intravenous infusion, Subcutaneous injection
In clinical studies, kisspeptin-10 is administered by intravenous infusion at doses of 0.1–1.0 nmol/kg. Subcutaneous administration is also studied but has lower bioavailability. Bolus vs continuous infusion produces different LH response patterns. Typical research protocols use 0.3 nmol/kg IV bolus. No established subcutaneous dosing regimen.

The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.

Side Effects

  • Generally well-tolerated in clinical studies — no serious adverse events reported at therapeutic doses[2][1]
  • No significant effect on anxiety or mood in human studies[2]
  • Sex-dependent effects on oxytocin — women show greater oxytocin response
  • Long-term effects of repeated administration not fully characterized[1]

Considering peptide research?

Kisspeptin-10 is not FDA-approved. Always consult a licensed healthcare provider before considering any peptide.

Use the Peptide Finder

Use the guided tool to narrow the safest next step.

Always consult a professional

Research & Evidence

References

  1. 1.Kisspeptin and its Current Clinical Status—A Systematic Review.. Curr Med Chem, 2025. "Comprehensive systematic review of kisspeptin clinical trials covering reproductive applications, dosing, and safety" [PMID: 38265397]
  2. 2.Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans.. J Clin Endocrinol Metab, 2025. "Kisspeptin administration successfully stimulated LH and FSH in human subjects without affecting anxiety, depression, or mood scores" [PMID: 40036336]
  3. 3.Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.. J Clin Invest, 2014. "Kisspeptin-54 (which contains the kisspeptin-10 sequence) successfully triggered oocyte maturation in IVF patients with lower OHSS risk" [PMID: 25036713]
  4. 4.Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome.. Hum Reprod, 2020. "Demonstrated that kisspeptin modulates gonadotropin secretion in PCOS patients, suggesting therapeutic potential" [PMID: 32510130]

Recommended Resources

The Peptide Protocols Handbook

Evidence-based reference guide covering mechanisms, research, and clinical applications.

View on Amazon

Third-Party Peptide Testing

Independent lab analysis to verify peptide purity and authenticity.

Learn More

Links may be affiliate links. See our disclosure.

Research Supplies

Equipment for responsible research-grade peptide handling and administration.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Kisspeptin-10 FAQ